108 related articles for article (PubMed ID: 20427703)
1. Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.
Leshchenko VV; Kuo PY; Shaknovich R; Yang DT; Gellen T; Petrich A; Yu Y; Remache Y; Weniger MA; Rafiq S; Suh KS; Goy A; Wilson W; Verma A; Braunschweig I; Muthusamy N; Kahl BS; Byrd JC; Wiestner A; Melnick A; Parekh S
Blood; 2010 Aug; 116(7):1025-34. PubMed ID: 20427703
[TBL] [Abstract][Full Text] [Related]
2. Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.
Pararajalingam P; Coyle KM; Arthur SE; Thomas N; Alcaide M; Meissner B; Boyle M; Qureshi Q; Grande BM; Rushton C; Slack GW; Mungall AJ; Tam CS; Agarwal R; Dawson SJ; Lenz G; Balasubramanian S; Gascoyne RD; Steidl C; Connors J; Villa D; Audas TE; Marra MA; Johnson NA; Scott DW; Morin RD
Blood; 2020 Jul; 136(5):572-584. PubMed ID: 32160292
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734.
Spriano F; Gaudio E; Cascione L; Tarantelli C; Melle F; Motta G; Priebe V; Rinaldi A; Golino G; Mensah AA; Aresu L; Zucca E; Pileri S; Witcher M; Brown B; Wahlestedt C; Giles F; Stathis A; Bertoni F
Blood Adv; 2020 Sep; 4(17):4124-4135. PubMed ID: 32882003
[TBL] [Abstract][Full Text] [Related]
4. Identification of a leukemia-initiating stem cell in human mast cell leukemia.
Eisenwort G; Sadovnik I; Schwaab J; Jawhar M; Keller A; Stefanzl G; Berger D; Blatt K; Hoermann G; Bilban M; Willmann M; Winding C; Sperr WR; Arock M; Rülicke T; Reiter A; Valent P
Leukemia; 2019 Nov; 33(11):2673-2684. PubMed ID: 30953030
[TBL] [Abstract][Full Text] [Related]
5. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.
Beà S; Valdés-Mas R; Navarro A; Salaverria I; Martín-Garcia D; Jares P; Giné E; Pinyol M; Royo C; Nadeu F; Conde L; Juan M; Clot G; Vizán P; Di Croce L; Puente DA; López-Guerra M; Moros A; Roue G; Aymerich M; Villamor N; Colomo L; Martínez A; Valera A; Martín-Subero JI; Amador V; Hernández L; Rozman M; Enjuanes A; Forcada P; Muntañola A; Hartmann EM; Calasanz MJ; Rosenwald A; Ott G; Hernández-Rivas JM; Klapper W; Siebert R; Wiestner A; Wilson WH; Colomer D; López-Guillermo A; López-Otín C; Puente XS; Campo E
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18250-5. PubMed ID: 24145436
[TBL] [Abstract][Full Text] [Related]
6.
Ferrero S; Rossi D; Rinaldi A; Bruscaggin A; Spina V; Eskelund CW; Evangelista A; Moia R; Kwee I; Dahl C; Di Rocco A; Stefoni V; Diop F; Favini C; Ghione P; Mahmoud AM; Schipani M; Kolstad A; Barbero D; Novero D; Paulli M; Zamò A; Jerkeman M; da Silva MG; Santoro A; Molinari A; Ferreri A; Grønbæk K; Piccin A; Cortelazzo S; Bertoni F; Ladetto M; Gaidano G
Haematologica; 2020 Jun; 105(6):1604-1612. PubMed ID: 31537689
[TBL] [Abstract][Full Text] [Related]
7. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
[TBL] [Abstract][Full Text] [Related]
8. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma.
Mohanty A; Sandoval N; Phan A; Nguyen TV; Chen RW; Budde E; Mei M; Popplewell L; Pham LV; Kwak LW; Weisenburger DD; Rosen ST; Chan WC; Müschen M; Ngo VN
Blood; 2019 Jan; 133(4):306-318. PubMed ID: 30530749
[TBL] [Abstract][Full Text] [Related]
9. New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies.
Scott DW; Abrisqueta P; Wright GW; Slack GW; Mottok A; Villa D; Jares P; Rauert-Wunderlich H; Royo C; Clot G; Pinyol M; Boyle M; Chan FC; Braziel RM; Chan WC; Weisenburger DD; Cook JR; Greiner TC; Fu K; Ott G; Delabie J; Smeland EB; Holte H; Jaffe ES; Steidl C; Connors JM; Gascoyne RD; Rosenwald A; Staudt LM; Campo E; Rimsza LM;
J Clin Oncol; 2017 May; 35(15):1668-1677. PubMed ID: 28291392
[TBL] [Abstract][Full Text] [Related]
10. Myeloid leukemia factor 1: A "double-edged sword" in health and disease.
Li Z; Yang Y; Wu K; Li Y; Shi M
Front Oncol; 2023; 13():1124978. PubMed ID: 36814822
[TBL] [Abstract][Full Text] [Related]
11. Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia.
Reßing N; Schliehe-Diecks J; Watson PR; Sönnichsen M; Cragin AD; Schöler A; Yang J; Schäker-Hübner L; Borkhardt A; Christianson DW; Bhatia S; Hansen FK
J Med Chem; 2022 Nov; 65(22):15457-15472. PubMed ID: 36351184
[TBL] [Abstract][Full Text] [Related]
12. Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.
LeBlanc FR; Hasanali ZS; Stuart A; Shimko S; Sharma K; Leshchenko VV; Parekh S; Fu H; Zhang Y; Martin MM; Kester M; Fox T; Liao J; Loughran TP; Evans J; Pu JJ; Spurgeon SE; Aladjem MI; Epner EM
Oncotarget; 2022; 13():986-1002. PubMed ID: 36093297
[TBL] [Abstract][Full Text] [Related]
13. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.
Zabihi M; Lotfi R; Yousefi AM; Bashash D
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1585-1606. PubMed ID: 35781526
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors.
Robinson N; Casement J; Gunter MJ; Huybrechts I; Agudo A; Barranco MR; Eichelmann F; Johnson T; Kaaks R; Pala V; Panico S; Sandanger TM; Schultze MB; Travis RC; Tumino R; Vineis P; Weiderpass E; Skinner R; Sharp L; McKay JA; Strathdee G
Br J Cancer; 2022 Jul; 127(2):288-300. PubMed ID: 35354948
[TBL] [Abstract][Full Text] [Related]
15. Research progress on epigenetics of small B-cell lymphoma.
Ruan X; Zhang R; Zhu H; Ye C; Wang Z; Dong E; Li R; Cheng Z; Peng H
Clin Transl Oncol; 2022 Aug; 24(8):1501-1514. PubMed ID: 35334078
[TBL] [Abstract][Full Text] [Related]
16. IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma.
Elfrink S; Ter Beest M; Janssen L; Baltissen MP; Jansen PWTC; Kenyon AN; Steen RM; de Windt D; Hagemann PM; Hess C; van Spronsen DJ; Hoevenaars B; van der Spek E; Xu-Monette ZY; Young KH; Kaffa C; Bervoets S; van Heek J; Hesius E; de Winde CM; Vermeulen M; van den Brand M; Scheijen B; van Spriel AB
Blood Adv; 2022 Apr; 6(7):2254-2266. PubMed ID: 35086136
[TBL] [Abstract][Full Text] [Related]
17. Epigenome-Wide Association Study of Prostate Cancer in African Americans Identifies DNA Methylation Biomarkers for Aggressive Disease.
Xu Y; Tsai CW; Chang WS; Han Y; Huang M; Pettaway CA; Bau DT; Gu J
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944472
[TBL] [Abstract][Full Text] [Related]
18. The clinical features, prognostic significance, and immune heterogeneity of CD37 in diffuse gliomas.
Yan X; Zhou Q; Zhu H; Liu W; Xu H; Yin W; Zhao M; Jiang X; Ren C
iScience; 2021 Nov; 24(11):103249. PubMed ID: 34755091
[TBL] [Abstract][Full Text] [Related]
19. SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma.
Jatiani SS; Christie S; Leshchenko VV; Jain R; Kapoor A; Bisignano P; Lee C; Kaniskan HÜ; Edwards D; Meng F; Laganà A; Youssef Y; Wiestner A; Alinari L; Jin J; Filizola M; Aggarwal AK; Parekh S
Clin Cancer Res; 2021 Aug; 27(16):4652-4663. PubMed ID: 34158358
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of Polycomb Repressive Complex-2 in Mantle Cell Lymphoma Confers Growth Advantage by Epigenetic Suppression of
Demosthenous C; Gupta SK; Sun J; Wang Y; Troska TP; Gupta M
Front Oncol; 2020; 10():1226. PubMed ID: 32850364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]